AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32071329 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2236
Study 34171526 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended scoring model for IANI risk assessment based on CBCT features
Number of subjects: 1573
Study 34171526 — intervention group
Group type: COMPARATOR
Intervention: Baseline model for IANI risk assessment
Number of subjects: 1573
Study 34125923 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (8 weeks, 5 days/week, daily cost of 74 PLN)
Number of subjects: 0
Study 34125923 — intervention group
Group type: COMPARATOR
Intervention: Standard care (costs from extra in-patient and out-patient rehabilitation)
Number of subjects: 0
Study 32307655 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI (genetically induced 1 unit increase)
Number of subjects: 101447
Study 32307655 — intervention group
Group type: EXPERIMENTAL
Intervention: Low and high BMI (observational)
Number of subjects: 101447
Study 32307655 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (observational)
Number of subjects: 101447
Study 32307655 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI (causal association)
Number of subjects: 101447
Study 35144608 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based education program
Number of subjects: 30
Study 35144608 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 34655945 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 72
Study 34655945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 35876325 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritionist-delivered coaching telephone calls over 8 weeks with an accompanying workbook on lifestyle changes
Number of subjects: 373
Study 35876325 — intervention group
Group type: COMPARATOR
Intervention: Workbook in eight mailings without nutritionist coaching calls
Number of subjects: 373
Study 35876325 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-pandemic onset group
Number of subjects: 373
Study 34221630 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 106
Study 34221630 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 106
Study 34719055 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual (traditional) evaluation
Number of subjects: 44
Study 34719055 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted evaluation
Number of subjects: 44
Study 32876479 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard risk information about diabetes or CRC
Number of subjects: 1276
Study 32876479 — intervention group
Group type: EXPERIMENTAL
Intervention: Low literacy risk information about diabetes or CRC
Number of subjects: 1276
Study 32876479 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention
Number of subjects: 1276
Study 32876479 — intervention group
Group type: COMPARATOR
Intervention: No self-affirmation intervention
Number of subjects: 1276
Study 35209847 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 8.3 μg/kg
Number of subjects: 135
Study 35209847 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 0.5 mg/kg
Number of subjects: 135
Study 35209847 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol 0.16 mg/kg
Number of subjects: 135
Study 33452038 — intervention group
Group type: EXPERIMENTAL
Intervention: 5∗ GRIP‐rated slip‐resistant footwear
Number of subjects: 4553
Study 33452038 — intervention group
Group type: COMPARATOR
Intervention: usual footwear (control group)
Number of subjects: 4553
Study 34465495 — intervention group
Group type: EXPERIMENTAL
Intervention: DAS-pass strategy (informational leaflet, patient held record, guidance by a specialized rheumatology nurse)
Number of subjects: 199
Study 34465495 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 199
Study 32746904 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soy supplementation (Lactobacillus delbrueckii fermented with soy flour, 3 sachets of 1g each)
Number of subjects: 50
Study 32746904 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soy supplementation
Number of subjects: 50
Study 32746904 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 50
Study 33893572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander-focused violence prevention program (Bringing in the Bystander-High School Curriculum)
Number of subjects: 2403
Study 35574910 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program with augmented reality system (smart-rehab group)
Number of subjects: 68
Study 35574910 — intervention group
Group type: COMPARATOR
Intervention: Written and pictorial home-based exercise program (control group)
Number of subjects: 68
Study 34446504 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg spironolactone daily, increasing to 100 mg until week 24
Number of subjects: 398
Study 34446504 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 398
Study 36217366 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-session Step-by-Step program with minimal guidance by trained peer-helpers
Number of subjects: 334
Study 36217366 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual (psychoeducational information on depression and anxiety and referrals to local community services)
Number of subjects: 334
Study 32454209 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/70 kg psilocybin
Number of subjects: 15
Study 34241706 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to integrative care (≥4 IO sessions/6 weeks)
Number of subjects: 225
Study 34241706 — intervention group
Group type: COMPARATOR
Intervention: Moderate and low adherence to integrative care (2-3 sessions or <2 sessions)
Number of subjects: 225
Study 32470981 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate diet (20% carbohydrate, 60% fat, 20% protein)
Number of subjects: 164
Study 32470981 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate diet (60% carbohydrate, 20% fat, 20% protein)
Number of subjects: 164
Study 36342289 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ) 12 ml twice daily
Number of subjects: 52
Study 36342289 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52
Study 36342289 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ)
Number of subjects: 52
Study 34425632 — intervention group
Group type: EXPERIMENTAL
Intervention: Shrinkage estimator proposed in the study
Number of subjects: 23551
Study 34425632 — intervention group
Group type: COMPARATOR
Intervention: Estimates just significant at the 5% level
Number of subjects: 23551
Study 34425632 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved power
Number of subjects: 23551
Study 32222267 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block
Number of subjects: 122
Study 33507722 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily GnRH agonist for luteal phase support (0.2 mg subcutaneous injection bid) following GnRH agonist trigger
Number of subjects: 44
Study 33507722 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy (hCG trigger [10000 IU] and progesterone bid [400 mg/BD] for LPS)
Number of subjects: 44
Study 32966811 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib (300 mg per day)
Number of subjects: 198
Study 32966811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 32966811 — intervention group
Group type: EXPERIMENTAL
Intervention: Surufatinib
Number of subjects: 198
Study 35760339 — intervention group
Group type: EXPERIMENTAL
Intervention: Y‐BTI + ATM
Number of subjects: 100
Study 35760339 — intervention group
Group type: EXPERIMENTAL
Intervention: Y‐BTI alone
Number of subjects: 100
Study 35760339 — intervention group
Group type: EXPERIMENTAL
Intervention: ATM alone
Number of subjects: 100
Study 35760339 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 100
Study 34450042 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia treatment for moderate or severe neonatal encephalopathy
Number of subjects: 0
Study 34450042 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 34619073 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment rationale for iCBT
Number of subjects: 662
Study 34619073 — intervention group
Group type: COMPARATOR
Intervention: No treatment rationale for iCBT
Number of subjects: 662
Study 32473974 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 64 mg
Number of subjects: 217
Study 32473974 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg
Number of subjects: 217
Study 32473974 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg
Number of subjects: 217
Study 32473974 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 217
Study 37294220 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral asymmetrical limb proprioceptive neuromuscular facilitation (PNF) exercises
Number of subjects: 150
Study 37294220 — intervention group
Group type: COMPARATOR
Intervention: Swiss ball exercises
Number of subjects: 150
Study 32047968 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent suture
Number of subjects: 44
Study 32047968 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable suture
Number of subjects: 44
Study 35619097 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal feedback, optional detail, and reduced cognitive load
Number of subjects: 638
Study 35619097 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal feedback, specific actions, patient voice, and reduced cognitive load
Number of subjects: 638
Study 35619097 — intervention group
Group type: COMPARATOR
Intervention: None of the six feedback modifications
Number of subjects: 638
Study 35619097 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of feedback modifications
Number of subjects: 638
Study 34129601 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate, fixed-dose, once daily for 3 days, dosed by body weight, using tablet formulation for adults/adolescents and pediatric granule formulation for children/infants under 20 kg.
Number of subjects: 7154
Study 34129601 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate
Number of subjects: 7154
Study 33326254 — intervention group
Group type: EXPERIMENTAL
Intervention: GD2/GD3 vaccine plus oral β-glucan
Number of subjects: 102
Study 33326254 — intervention group
Group type: EXPERIMENTAL
Intervention: β-glucan
Number of subjects: 102
Study 33326254 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-GD2-IgG1 titer ≥ 150 ng/mL by week 8
Number of subjects: 102
Study 33326254 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior episodes of disease progression and time from last progression to vaccine
Number of subjects: 102
Study 33081715 — intervention group
Group type: EXPERIMENTAL
Intervention: PAM-based intervention with motivational interviewing
Number of subjects: 0
Study 33081715 — intervention group
Group type: COMPARATOR
Intervention: PAM-based intervention (control group)
Number of subjects: 0
Study 33078664 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% human albumin
Number of subjects: 76
Study 33078664 — intervention group
Group type: COMPARATOR
Intervention: Conventional blood prime
Number of subjects: 76
Study 33351083 — intervention group
Group type: EXPERIMENTAL
Intervention: Manhood 2.0 program (18 hours)
Number of subjects: 866
Study 33351083 — intervention group
Group type: COMPARATOR
Intervention: Job-readiness training (control group, 18 hours)
Number of subjects: 866
Study 33351083 — intervention group
Group type: EXPERIMENTAL
Intervention: Manhood 2.0 program
Number of subjects: 866
Study 34610286 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% hypertonic dextrose injection
Number of subjects: 57
Study 34610286 — intervention group
Group type: COMPARATOR
Intervention: 5% normal saline (control group)
Number of subjects: 57
Study 32921992 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV with ARM
Number of subjects: 62
Study 32921992 — intervention group
Group type: COMPARATOR
Intervention: LPV only
Number of subjects: 62
Study 35728160 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy review at the hospital (follow-up (a))
Number of subjects: 200
Study 35728160 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up with high-risk human papilloma virus (HrHPV) and smear test in the community (follow-up (b))
Number of subjects: 200
Study 35728160 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of follow-up options (follow-up (c))
Number of subjects: 200
Study 35728160 — intervention group
Group type: COMPARATOR
Intervention: Choice of follow-up (c)
Number of subjects: 200
Study 33352599 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (cycling generated by the own subject)
Number of subjects: 25
Study 33352599 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (cycling generated by external force)
Number of subjects: 25
Study 33352599 — intervention group
Group type: COMPARATOR
Intervention: Inactive recovery (no-cycling)
Number of subjects: 25
Study 36104179 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPUS therapy (1.3 MPa, 32 cycles, 5% duty cycle, 1 hour, 3 times a week for 6 sessions over 1.5 years)
Number of subjects: 22
Study 36104179 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPUS therapy
Number of subjects: 22
Study 36104179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 35032465 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 220
Study 35032465 — intervention group
Group type: COMPARATOR
Intervention: Control (no binder)
Number of subjects: 220
Study 33933305 — intervention group
Group type: EXPERIMENTAL
Intervention: Approximating technique (AP)
Number of subjects: 36
Study 33933305 — intervention group
Group type: COMPARATOR
Intervention: Overlapping technique (OV)
Number of subjects: 36
Study 32422100 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Number of subjects: 0
Study 32422100 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0
Study 35246404 — intervention group
Group type: EXPERIMENTAL
Intervention: CARE‐Express
Number of subjects: 71
Study 35246404 — intervention group
Group type: COMPARATOR
Intervention: ESWC
Number of subjects: 71
Study 32295890 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS)
Number of subjects: 620
Study 35124675 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial interdisciplinary intervention (physical exercise, Mediterranean diet advice, assessment of inadequate prescribing, social assessment) for 6 months
Number of subjects: 200
Study 35124675 — intervention group
Group type: COMPARATOR
Intervention: Standard of care primary healthcare treatment
Number of subjects: 200
Study 35124675 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial interdisciplinary intervention
Number of subjects: 200
Study 33090088 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepresence robot (TP)
Number of subjects: 43
Study 33090088 — intervention group
Group type: COMPARATOR
Intervention: In-person (IP)
Number of subjects: 43
Study 32590064 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-high compression stockings (CS) and sequential compression devices (SCDs)
Number of subjects: 66
Study 32590064 — intervention group
Group type: COMPARATOR
Intervention: Sequential compression devices (SCDs) alone
Number of subjects: 66
Study 34378269 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia endocrowns
Number of subjects: 53
Study 34378269 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid ceramic endocrowns
Number of subjects: 53
Study 34378269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium disilicate endocrowns
Number of subjects: 53
Study 34378269 — intervention group
Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 53
Study 32294530 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg every 2 weeks)
Number of subjects: 736
Study 32294530 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus tremelimumab (durvalumab 20 mg/kg q4w plus tremelimumab 1 mg/kg q4w × 4, then durvalumab 10 mg/kg q2w)
Number of subjects: 736
Study 32294530 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC: cetuximab, a taxane, methotrexate, or a fluoropyrimidine)
Number of subjects: 736
Study 35440449 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation (PN) intervention aimed at decreasing non‐adherence to receipt of infant hearing diagnosis within 3 months after birth.
Number of subjects: 0
Study 35440449 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation (PN) intervention
Number of subjects: 0
Study 33704831 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy (CP) including prolonged slow expiration (PSE) and assisted cough (AC)
Number of subjects: 31
Study 33704831 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical treatment alone)
Number of subjects: 31
Study 33030225 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose, Open Food Challenge
Number of subjects: 0
Study 33030225 — intervention group
Group type: COMPARATOR
Intervention: Double-Blind, Placebo-Controlled Data
Number of subjects: 0
Study 36364716 — intervention group
Group type: EXPERIMENTAL
Intervention: Food guiding booklet (G)
Number of subjects: 0
Study 36364716 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinner set (D)
Number of subjects: 0
Study 36364716 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary skills
Number of subjects: 0
Study 36364716 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational level
Number of subjects: 0
Study 36364716 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly income of 3000−5000
Number of subjects: 0
Study 35854390 — intervention group
Group type: EXPERIMENTAL
Intervention: DELTA Xtend® Reverse Shoulder System Lateralized Glenosphere Line Extension
Number of subjects: 122
Study 35854390 — intervention group
Group type: COMPARATOR
Intervention: Standard DELTA Xtend® Reverse Shoulder System
Number of subjects: 122
Study 33992562 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroreflex Activation Therapy (BAT) plus guideline-directed medical therapy (GDMT)
Number of subjects: 264
Study 33992562 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 264
Study 32380138 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 102
Study 32380138 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (two forms)
Number of subjects: 102
Study 32380138 — intervention group
Group type: COMPARATOR
Intervention: No-intervention usual care control
Number of subjects: 102
Study 35143442 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) therapy combined with 4% hydroquinone (HQ) cream
Number of subjects: 30
Study 35143442 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone (HQ) cream alone
Number of subjects: 30
Study 33586842 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and adjuvant radiation therapy
Number of subjects: 0
Study 33586842 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 32012053 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Management Strategy for Health-based electronic program (Smart Healthing)
Number of subjects: 106
Study 32012053 — intervention group
Group type: COMPARATOR
Intervention: Basic educational material concerning disease control
Number of subjects: 106
Study 35787137 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated prospective memory task with lower focality
Number of subjects: 226
Study 35787137 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated prospective memory task with higher focality
Number of subjects: 226
Study 35787137 — intervention group
Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with high process overlap in a zero-target condition
Number of subjects: 226
Study 35787137 — intervention group
Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with lower focality
Number of subjects: 226
Study 35787137 — intervention group
Group type: EXPERIMENTAL
Intervention: Deactivated prospective memory task with higher focality
Number of subjects: 226
Study 32103439 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraventricularly delivered, sustained-release nimodipine (EG-1962)
Number of subjects: 5
Study 32103439 — intervention group
Group type: COMPARATOR
Intervention: Standard of care oral nimodipine (NEWTON 2)
Number of subjects: 5
Study 34057590 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe burnout among primary care workers
Number of subjects: 2940
Study 34057590 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals' characteristics associated with severe burnout
Number of subjects: 2940
Study 34057590 — intervention group
Group type: EXPERIMENTAL
Intervention: Team factors associated with severe burnout
Number of subjects: 2940
Study 34057590 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care center factors associated with severe burnout
Number of subjects: 2940
Study 35013782 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcrestal sinus floor elevation (tSFE)
Number of subjects: 45
Study 35013782 — intervention group
Group type: COMPARATOR
Intervention: Lateral sinus floor elevation (lSFE)
Number of subjects: 45
Study 34330855 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTI-MOBIL (mobile technology)
Number of subjects: 120
Study 34330855 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTI-VISIO (videoconferencing)
Number of subjects: 120
Study 34330855 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (standard care)
Number of subjects: 120
Study 32680475 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural group counselling program for smoking cessation, optional nicotine replacement therapy, environmental smoking reduction measures
Number of subjects: 416
Study 32680475 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 416
Study 33513064 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Hypnotic Induction Profile (rHIP)
Number of subjects: 56